David Fuller
Directeur Technique/Scientifique/R&D chez DIMERIX LIMITED
Fortune : 1 548 $ au 30/04/2024
Postes actifs de David Fuller
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ADALTA LIMITED | Directeur/Membre du Conseil | 22/07/2020 | - |
| DIMERIX LIMITED | Directeur Technique/Scientifique/R&D | 23/10/2023 | - |
EpiAxis Therapeutics Pty Ltd.
 EpiAxis Therapeutics Pty Ltd. BiotechnologyHealth Technology EpiAxis Therapeutics Pty Ltd. engages in biotechnology company. It pursuing a preclinical and clinical drug development program directed at the prevention of metastatic disease by targeting the pivotal enzyme system controlling the proliferation of cancer stem cells. The company was founded by Jeremy Chrisp and Sudha Rao and is headquartered in Canberra, Australia. | Président | - | - |
Historique de carrière de David Fuller
Anciens postes connus de David Fuller
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| RACE ONCOLOGY LIMITED | Directeur Technique/Scientifique/R&D | 01/07/2021 | 11/11/2022 |
Statistiques
Internationale
| Australie | 5 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 2 |
| Director/Board Member | 1 |
| Chairman | 1 |
Sectorielle
| Health Technology | 5 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| DIMERIX LIMITED | Health Technology |
| ADALTA LIMITED | Health Technology |
| RACE ONCOLOGY LIMITED | Health Technology |
| Entreprise privées | 1 |
|---|---|
EpiAxis Therapeutics Pty Ltd.
EpiAxis Therapeutics Pty Ltd. BiotechnologyHealth Technology EpiAxis Therapeutics Pty Ltd. engages in biotechnology company. It pursuing a preclinical and clinical drug development program directed at the prevention of metastatic disease by targeting the pivotal enzyme system controlling the proliferation of cancer stem cells. The company was founded by Jeremy Chrisp and Sudha Rao and is headquartered in Canberra, Australia. | Health Technology |
- Bourse
- Insiders
- David Fuller
- Expérience